A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

Clinical trial NCT07355075 · RECRUITING

Trial details

NCT number: NCT07355075
Sponsor: Turn Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Eczema Atopic Dermatitis Eczema Atopic Dermatitis

Start date: 2025-07-11
Primary completion: 2026-07-10
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.